SCHEMBL798382

SCHEMBL798382

NC(=O)c1ncccc1-c1cnno1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 2/20 0.38
MKNK2 Q9HBH9 2/20 0.38
IRAK4 Q9NWZ3 1/20 0.35
GRM5 P41594 1/20 0.35
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
BLM P54132 1/20 0.34
AGER Q15109 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
F7 P08709 1/20 0.34
F3 P13726 1/20 0.34
SARM1 Q6SZW1 1/20 0.34
SIRT2 Q8IXJ6 1/20 0.34
SIRT6 Q8N6T7 1/20 0.34
SIRT1 Q96EB6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL797912 0.86 KDM4E (0.46) KDM4EALDH1A1CYP3A4MAPTALOX15
SCHEMBL4560363 0.78 MKNK1 (0.50) MKNK1MKNK2IRAK4KDM4EALDH1A1
SCHEMBL3673661 0.76 BCAT2 (0.49) GRM5KDM4EALDH1A1MAPTTSHR
SCHEMBL29771505 0.76 ADORA2A (0.39) MKNK1MKNK2IRAK4KDM4EALDH1A1
SCHEMBL798359 0.74 KCNA5 (0.47)
SCHEMBL17028059 0.73 MKNK1 (0.50) MKNK1MKNK2IRAK4GRM5KDM4E
SCHEMBL2576181 0.72 NPC1 (0.38) KDM4EALDH1A1MAPTNPSR1MEN1
SCHEMBL29594571 0.71 MKNK1 (0.56) MKNK1MKNK2ALDH1A1CYP3A4F7
SCHEMBL30165669 0.71 MKNK1 (0.56) MKNK1MKNK2ALDH1A1CYP3A4F7
SCHEMBL2572631 0.71 MKNK1 (0.56) MKNK1MKNK2ALDH1A1CYP3A4F7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616465-A1 TRIAZINE-OXADIAZOLES Novartis AG (CH) 2013-07-24 EP disclosed
WO-2012035023-A1 TRIAZINE-OXADIAZOLES NOVARTIS AG (CH) 2012-03-22 WO disclosed